Cat.#: ASSD-138
| Description | A3AR covalent antagonist.Binds irreversibly. Apparent pKi values at A3ARs are 6.9 and 8.0 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-(8-Methoxy-2,4-dioxo-3-propylpurino[7,8-a]pyridin-1-yl)propylcarbamoyl]benzenesulfonyl fluoride |
| Molecule Weight | 517.5 |
| Molecular formula | C23H24FN5O6S |
| PubChem identifier | 155513958 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-104 | Hoechst 33258 (AC104) | 25 mg, 100 mg | inquiry |
| ASSD-111 | Propidium Iodide (AC111) | 10 mg, 50 mg | inquiry |
| ASSD-184 | BTA-1 (AC184) | 10 mg | inquiry |
| ASSD-146 | Pyronin Y (AC146) | 1 g, 5g | inquiry |
| ASSD-175 | 5-Carboxyfluorescein-N-hydroxysuccinimide Ester (AC175) | 25 mg | inquiry |
| ASSD-154 | Brilliant Blue R-250 (AC154) | 1g, 5g | inquiry |
| ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg | inquiry |
| ASSD-218 | 6-Carboxy-2′,7′-dichlorofluorescein-3′,6′-diacetatesuccinimidyl Ester (AC218) | 25 mg | inquiry |
| ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
| ASSD-181 | Nitrofluorescein, Isomer 1 (AC181) | 1 g | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.